Mitazalimab Antibody
Mitazalimab (ADC-1013) is a CD40-targeting agonistic monoclonal IgG antibody. It activates antigen-presenting cells, induces transient peripheral transcriptomic changes, and demonstrates antitumor activity, making it a valuable tool for immuno-oncology research in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
ADC-1013, AD-1013, CD40, JNJ64457107, JNJ-64457107, JNJ7107, JNJ 7107
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.93 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.42 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1052004 Inquire
Recombinant Bacillus cereus Polyribonucleotide nucleotidyltransferase (pnp), partial
Sign In for Pricing
View Details 
C8376-25E-APC 200 µL
CXCR7, CT (G-protein Coupled Receptor 159, Chemokine Orphan Receptor 1, G-protein Coupled Receptor RDC1 Homolog, RDC-1, C-X-C Chemokine Receptor Type 7, CXC-R7, CXCR-7, CMKOR1, GPR159, RDC1) (APC) discontinued
Sign In for Pricing
View Details